MedTrace Logo

Psychotherapy and Pharmacotherapy in Dissociative Disorders

NCT00630981 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2009-04-20

No results posted yet for this study

Summary

The purpose of this observational study is to measure the efficacy of a specific combined treatment (psychotherapy and pharmacotherapy) on patients with dissociative disorders, in terms of patients with a favorable outcome by means of the Dissociative Experiences Scale (DES).

Conditions

  • Dissociative Disorders

Interventions

BEHAVIORAL

Psychotherapy

Specific psychotherapy for dissociative disorders

DRUG

Pharmacological treatment (Quetiapine and/or Escitalopram)

Quetiapine for psychotic symptoms/Escitalopram if depressive disorders

Sponsors & Collaborators

  • Espace Hogan

    lead OTHER

Principal Investigators

  • Cristian Damsa, MD · HUG

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-04-30
Completion
2009-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00630981 on ClinicalTrials.gov